Insider Transactions in Q3 2023 at Charles River Laboratories International, Inc. (CRL)
Insider Transaction List (Q3 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 24
2023
|
Richard F Wallman Director |
BUY
Open market or private purchase
|
Indirect |
1,000
+50.0%
|
$198,000
$198.79 P/Share
|
|
Aug 10
2023
|
Michael Gunnar Knell CSVP&Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
1,471
-12.89%
|
$317,736
$216.54 P/Share
|
|
Aug 10
2023
|
Michael Gunnar Knell CSVP&Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,471
+11.42%
|
$211,824
$144.67 P/Share
|
|
Aug 10
2023
|
William D Barbo Corporate Executive VP & CCO |
BUY
Exercise of conversion of derivative security
|
Direct |
5,511
+37.71%
|
$793,584
$144.67 P/Share
|
|
Aug 10
2023
|
William D Barbo Corporate Executive VP & CCO |
SELL
Open market or private sale
|
Direct |
5,763
-61.6%
|
$1,250,571
$217.24 P/Share
|
|
Aug 10
2023
|
Joseph W La Plume EVP, Corp Strategy & Develop |
SELL
Open market or private sale
|
Direct |
700
-2.73%
|
$151,200
$216.52 P/Share
|
|
Aug 10
2023
|
James C Foster Chairman, President and CEO |
SELL
Bona fide gift
|
Direct |
2,500
-1.25%
|
-
|
|
Jul 03
2023
|
Martin Mackay Director |
BUY
Grant, award, or other acquisition
|
Direct |
95
+0.81%
|
-
|